European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions
Molecular Oncology, Volume 20, Issue 1, Page 96-116, January 2026.The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations related to cancer‐causing infections, namely H. pylori, HPV, HBV, HCV and HIV, positioned as recommendation number 12.
Catharina Johanna Alberts +18 more
wiley +1 more source
Severe Acute Hepatitis B Treated with Entecavir
Mediterranean Journal of Hematology and Infectious Diseases, 2011 Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B.
Giuseppe Vittorio Luigi De Socio +3 more
doaj +1 more source
A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy. [PDF]
PLoS ONE, 2015 Nucleos(t)ide analogues reduce the incidence of hepatitis B virus (HBV) reactivation in cancer patients undergoing systemic cytotoxic chemotherapy but the experience of solid tumors remains limited. Aims. The aim of this study was to compare the efficacy
Wen-Chi Chen +9 more
doaj +1 more source
Identification of hepatitis B virus DNA reverse transcriptase variants associated with partial response to entecavir [PDF]
, 2015 published_or_final_versio
Fung, JYY, Lai, CL, Wong, DKH, Yuen, RMF
core
Future prevention and treatment of chronic hepatitis B infection [PDF]
, 2012 Vaccination for hepatitis B virus (HBV) infection and treatment for chronic hepatitis B, while effective for primary prevention and control of the disease, still have their limitations. Global coverage of HBV immunization needs improvement.
Fung, J, Lai, CL, Seto, WK, Yuen, MF
core +1 more source
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
Small Methods, Volume 10, Issue 2, 22 January 2026.The review presents a comprehensive overview of each component of lipid nanoparticles（LNPs）and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu +6 more
wiley +1 more source
Clinical utility of entecavir for chronic hepatitis B in Chinese patients
Drug Design, Development and Therapy, 2013 Jiyao WangZhongshan Hospital, Fudan University, Shanghai, Key Laboratory of Medical Molecular Virology of MOE/MOH, Shanghai, People’s Republic of ChinaAbstract: The People’s Republic of China has one of the highest rates of hepatitis B virus (
Wang JY
doaj
Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management [PDF]
, 2017 Hepatitis B virus (HBV) reactivation during or after chemotherapy in patients with breast cancer has become a remarkable clinical problem. Prophylactic nucleos(t)ide analogues (NAs) are recommended for patients with breast cancer who are hepatitis B ...
Gong, Chang +6 more
core +2 more sources
Alimentary Pharmacology &Therapeutics, Volume 63, Issue 1, Page 132-144, January 2026.In East Asian patients with chronic hepatitis B, rates of virologic suppression through 5 years were high in those treated continuously with tenofovir alafenamide (TAF) and in those switched from tenofovir disoproxil fumarate (TDF) to TAF. Improved renal and bone safety was observed in patients switching from TDF to TAF.
Grace Lai‐Hung Wong +15 more
wiley +1 more source
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management [PDF]
, 2018 Chronic hepatitis B (CHB) is a major global health problem affecting an estimated 350 million people with more than 786000 individuals dying annually due to complications, such as cirrhosis, liver failure and hepatocellular carcinoma (HCC).
Chauhan, Ranjit +7 more
core +1 more source